Substance use among pregnant women is a major public health issue. Both prescription
opioid use and illicit opioid abuse have increased dramatically in recent years. Prolonged in …

Background: Canada has featured the second-highest levels of prescription opioid (PO) use
globally behind the United States, and reported extensive PO-related harms (eg, non …

Importance A recent epidemic of opioid abuse has been described in many communities,
although population-based data on trends in use in pregnancy and perinatal outcomes after …

OBJECTIVES Evidence on the perinatal health of mother-infant dyads affected by opioids is
limited. Elevated risks of opioid-related harms for people with opioid use disorder (OUD) …

Background: The Academy of Breastfeeding Medicine (ABM) revised the 2015 version of the
substance use disorder (SUD) clinical protocol to review the evidence and provide updated …

OBJECTIVES: To evaluate the generalizability of stringent protocol-driven weaning in
improving total duration of opioid treatment and length of inpatient hospital stay after …

Objectives We determined trends over time in the prevalence of neonatal drug withdrawal
syndrome (NWS) in England compared with that reported in the USA, Western (W) Australia …

Background There is a paucity of data characterizing mother-infant pairs with prenatal opioid
dependence in Canada. We therefore conducted a study of relevant births in Ontario from …

Opioid use in pregnancy has increased in parallel to the opioid crisis observed in the
general population. Rising rates of peripartum opioid use pose a significant public health …

Background Neonatal abstinence syndrome (NAS) is a collection of symptoms that occurs
primarily due to antenatal opioid exposure. National data on incidence, hospital resource …